2024 Cancer Symposium: New Frontiers in Peritoneal Carcinomatosis

PRESENTED BY THE AND AT

Englewood Health's Lefcourt Family Cancer Treatment and Wellness Center is excited to host its annual symposium, New Frontiers in Peritoneal Carcinomatosis. This year's event will focus on exploring the latest advancements in the diagnosis, treatment, and management of peritoneal carcinomatosis. The symposium will highlight innovative approaches and interdisciplinary strategies designed to improve patient outcomes for this complex condition.

Peritoneal carcinomatosis, often associated with advanced cancers, requires a nuanced and collaborative treatment strategy involving multiple medical disciplines. This event will bring together leading experts across oncology, pathology, radiology, anesthesiology, and palliative care, offering attendees a holistic view of how emerging technologies and therapies are transforming the field.

The symposium will cover a wide range of important topics, including:

• Advances in surgical interventions and chemotherapy delivery methods
• Diagnostic breakthroughs through pathology and imaging
• The role of palliative care in enhancing the quality of life
• Innovative anesthesiology practices supporting complex surgical treatments

This event is ideal for healthcare professionals looking to expand their knowledge of peritoneal carcinomatosis and engage in discussions about the latest approaches to multidisciplinary patient care. The symposium may be of particular interest to healthcare professionals in primary care, medical oncology, gastroenterology, colon and rectal surgery, obstetrics and gynecology, nursing, infusion, and other disciplines who care for patients with cancer. All are welcome.

Attendees will have an opportunity to interact with expert faculty and colleagues from across various disciplines, thereby encouraging a multidisciplinary approach to treatment that will improve patient outcomes.

4:00 p.m. – 5:00 p.m. | Welcome / Networking

5:00 p.m. – 5:10 p.m. | Introduction and Opening Remarks

Nimesh Nagarsheth, MD (Moderator)

Gynecologic Oncology

5:10 p.m. – 5:25 p.m. | New Horizons on Peritoneal Carcinomatosis, HIPEC, and Beyond

Cherif Boutros, MD

Medical Director of The Lefcourt Family Cancer Treatment and Wellness Center

5:25 p.m. – 5:40 p.m. | Mesothelial Cell: Friend or Foe

Ana M. Burga, MD

Chief of Pathology

5:40 p.m. – 5:55 p.m. | Imaging of Peritoneal Disease

Mark Shapiro, MD

Chief of Radiology

6:00 p.m. – 7:00 p.m. | Dinner

7:00 p.m. – 7:15 p.m.

Bernard Baez, MD

Anesthesiology

7:15 p.m. – 7:30 p.m. | Chemotherapy for Peritoneal Carcinomatosis - The Good, The Bad, and The Ugly

Rini Palathingal, MD

Hematology, Oncology

7:30 p.m. – 7:45 p.m. | A Palliative Approach to Management of Peritoneal Carcinomatosis

Vinnidhy Dave, DO

Director of Palliative Medicine

7:45 p.m. – 8:00 p.m. | Q&A and Closing Remarks

Nimesh Nagarsheth, MD (Moderator)

Gynecologic Oncology

Online registration closes at 4:00 p.m. on Thursday, November 14, 2024.

Englewood Hospital
Chiang Auditorium
350 Engle Street
Englewood, NJ

This activity has been approved for AMA PRA Category 1 Credit(s)™. CEU credits pending.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Englewood Health. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Host or Publisher Englewood Health